Searched for
GRANULES STOCK PRICE
For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsAs the stock market witnesses a recovery, what one should watch for is market breadth. Also, check which sectors are leading the rally. Why...
- For investors with long-term perspective: 5 mid-cap stocks from different sectors with upside potential of up to 30%Even before the US-Israel-Iran war began, there was a sort of readjustment taking place in the mid-cap segment – a kind of valuation readju...
- Ahead of Market: 10 things that will decide stock market action on TuesdayThe Nifty 50 and BSE Sensex rebounded on broad-based buying led by pharma, IT, auto and metals. Volatility eased, while analysts signalled ...
- In war, anything can happen; in investing, only management matters. 6 stocks from different sectors with upside potential of up to 27%Net margin is a useful metric. It tells you how much profit remains after costs, interest, and tax are deducted from revenue. But it does n...
- These large-, mid- and small-cap stocks can give more than 22% return in 1 year, according to analystsWhen a market is in a secular correction due to fears that the economy might take a hit for some reason, the fall is generally across the b...
- Correction may be opportunity for some: 5 mid-cap stocks from different sectors with an upside potential up to 28%Will they? Won’t they? Even as uncertainty persists over the proposed second round talks between the US and Iran, markets across the globe ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Ahead of Market: 10 things that will decide stock market action on ThursdayThe Nifty 50 and BSE Sensex surged over 1.6% after US–Iran talks optimism boosted sentiment, driving broad-based buying. Falling volatility...
- Granules India shares in focus after US FDA flags observation at Telangana API facilityThe US FDA issued a Form 483 observation for its Telangana API facility. While not a final non-compliance verdict, the company plans a time...
- Buy Granules India, target price Rs 625: Motilal Oswal SecuritiesMotilal Oswal Securities has recommended buying shares of Granules India Ltd. with a target price of Rs 625. Currently priced at Rs 535.45,...
- Technical Stock Pick: 20% rally in 3 months! This pharma stock breaks out from a rounding bottom pattern; time to buy?Short-term traders can look to buy the stock now for a target of Rs 590 in the next 3 months, suggest experts.
- Stock Radar: Up 50% in 6 months! Why Granules India could keep hitting record highs: Ajit MishraThe pharma stock rose from Rs 291 on August 14 to Rs 435 recorded on February 15, which translates into an upside of about 50% in six month...
- Stock Radar: This pharma stock is on verge of breakout from 6-month consolidation; what should traders do?The stock hit a 52-week high of Rs 381 on November 4, 2022, but failed to hold on to the momentum. It has moved in a range since January 20...
- Chart Check: Granules India hits fresh 52-week high in November; time to buy?“The stock price started its up move from Rs 84 (July 2019). The stock made a high of Rs 438 in Dec 2020 accompanied by Higher Bottoms & To...
- Chart Check: A breakout from inverse head & shoulder pattern could push this pharma stock to fresh highsThe stock saw a vertical move to Rs 330 in August and post that it started consolidating. The recent price action helped the stock to break...
- Granules India rallies 6% as PI Industries looks to buy promoter stakeGranules is a large-scale vertically integrated company that manufactures API, intermediates and finished dosages and has seven manufacturi...
- Present tense, future perfect for this pharma multibagger; grab it if you have the patienceAnalysts acknowledge the supply-side challenges and the burden of rising raw material costs in the near term.
- Granules India earmarks capex of Rs 1,000 crore till FY24The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants.
- After 1,800% jump in 10 years, this pharma stock is in no mood to haltThe company is one of the active ingredients and drug formulations makers.
Load More
